{"id":"https://openalex.org/W4366769401","doi":"https://doi.org/10.1186/s12967-023-04117-3","title":"The \u201cGreat Debate\u201d at Immunotherapy Bridge 2022, Naples, November 30th\u2013December 1st, 2022","display_name":"The \u201cGreat Debate\u201d at Immunotherapy Bridge 2022, Naples, November 30th\u2013December 1st, 2022","publication_year":2023,"publication_date":"2023-04-22","ids":{"openalex":"https://openalex.org/W4366769401","doi":"https://doi.org/10.1186/s12967-023-04117-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/37087493","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10122806"},"language":"en","primary_location":{"id":"doi:10.1186/s12967-023-04117-3","doi":"https://doi.org/10.1186/s12967-023-04117-3","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1186/s12967-023-04117-3","pdf_url":"https://link.springer.com/content/pdf/10.1186/s12967-023-04117-3.pdf","source":{"id":"https://openalex.org/S142026636","display_name":"Journal of Translational Medicine","issn_l":"1479-5876","issn":["1479-5876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Translational Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1186/s12967-023-04117-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029398339","display_name":"Paolo A. Ascierto","orcid":"https://orcid.org/0000-0002-8322-475X","observed_orcids":["https://orcid.org/0000-0002-8322-475X"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Paolo A. Ascierto","raw_affiliation_strings":["Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\", Naples, Italy. paolo.ascierto@gmail.com","Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS \u201cFondazione G. Pascale\u201d, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0002-8322-475X","affiliations":[{"raw_affiliation_string":"Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\", Naples, Italy. paolo.ascierto@gmail.com","institution_ids":["https://openalex.org/I4210141868"]},{"raw_affiliation_string":"Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS \u201cFondazione G. Pascale\u201d, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065556543","display_name":"Renier J. Brentjens","orcid":"https://orcid.org/0000-0002-3364-5388","observed_orcids":["https://orcid.org/0000-0002-3364-5388"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renier Brentjens","raw_affiliation_strings":["Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026861780","display_name":"Samir N. Khleif","orcid":"https://orcid.org/0000-0003-2707-5224","observed_orcids":["https://orcid.org/0000-0003-2707-5224"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samir N. Khleif","raw_affiliation_strings":["The Loop Immuno Oncology Laboratory, Georgetown University Medical School, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Loop Immuno Oncology Laboratory, Georgetown University Medical School, Washington, DC, USA","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009400324","display_name":"Kunle O. Odunsi","orcid":"https://orcid.org/0000-0002-4444-7651","observed_orcids":["https://orcid.org/0000-0002-4444-7651"]},"institutions":[{"id":"https://openalex.org/I4390039251","display_name":"University of Chicago Medicine Comprehensive Cancer Center","ror":"https://ror.org/042wftp98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865","https://openalex.org/I4390039251"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kunle Odunsi","raw_affiliation_strings":["University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA","institution_ids":["https://openalex.org/I4390039251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007244861","display_name":"Katayoun Rezvani","orcid":"https://orcid.org/0000-0002-9599-2246","observed_orcids":["https://orcid.org/0000-0002-9599-2246"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katayoun Rezvani","raw_affiliation_strings":["Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088355904","display_name":"Marco Ruella","orcid":"https://orcid.org/0000-0003-4301-5811","observed_orcids":["https://orcid.org/0000-0003-4301-5811"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marco Ruella","raw_affiliation_strings":["Center for Cellular Immunotherapies and Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cellular Immunotherapies and Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan J. Sullivan","raw_affiliation_strings":["Melanoma Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067266240","display_name":"Bernard A. Fox","orcid":"https://orcid.org/0000-0002-4452-5947","observed_orcids":["https://orcid.org/0000-0002-4452-5947"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bernard A. Fox","raw_affiliation_strings":["Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Cancer Institute, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Cancer Institute, Portland, OR, USA","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049243227","display_name":"Igor J. Puzanov","orcid":"https://orcid.org/0000-0002-9803-3497","observed_orcids":["https://orcid.org/0000-0002-9803-3497"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Igor Puzanov","raw_affiliation_strings":["Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5029398339"],"corresponding_institution_ids":["https://openalex.org/I4210141868"],"apc_list":{"value":3490,"currency":"USD","value_usd":3490},"apc_paid":{"value":3490,"currency":"USD","value_usd":3490},"fwci":0.1214,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.40603344,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"21","issue":"1","first_page":"275","last_page":"275"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.03790000081062317,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.9190000295639038},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7789999842643738},{"id":"https://openalex.org/keywords/peripheral-blood-biomarkers","display_name":"peripheral blood biomarkers","score":0.7770000100135803},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9190000295639038},{"id":"https://openalex.org/keywords/nk-cell-therapy","display_name":"NK cell therapy","score":0.9070000052452087},{"id":"https://openalex.org/keywords/audience-voting","display_name":"audience voting","score":0.7599999904632568}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7572362422943115},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6390253305435181},{"id":"https://openalex.org/C3019255331","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive immunotherapy","level":4,"score":0.5715115666389465},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5506059527397156},{"id":"https://openalex.org/C100776233","wikidata":"https://www.wikidata.org/wiki/Q2532492","display_name":"Bridge (graph theory)","level":2,"score":0.5358957052230835},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5230416059494019},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38347330689430237},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.360698401927948},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2524501085281372}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12967-023-04117-3","doi":"https://doi.org/10.1186/s12967-023-04117-3","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1186/s12967-023-04117-3","pdf_url":"https://link.springer.com/content/pdf/10.1186/s12967-023-04117-3.pdf","source":{"id":"https://openalex.org/S142026636","display_name":"Journal of Translational Medicine","issn_l":"1479-5876","issn":["1479-5876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Translational Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10122806","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10122806","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10122806/pdf/12967_2023_Article_4117.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Transl Med","raw_type":"Text"},{"id":"pmid:37087493","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37087493","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of translational medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:86cf15cf8d4442faa9a75236149ec41e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/86cf15cf8d4442faa9a75236149ec41e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-10 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12967-023-04117-3","doi":"https://doi.org/10.1186/s12967-023-04117-3","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1186/s12967-023-04117-3","pdf_url":"https://link.springer.com/content/pdf/10.1186/s12967-023-04117-3.pdf","source":{"id":"https://openalex.org/S142026636","display_name":"Journal of Translational Medicine","issn_l":"1479-5876","issn":["1479-5876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Translational Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1472606672","display_name":"Resistance To Targeted Immunotherapies:CART19 as a Paradigm","funder_award_id":"K99CA212302","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1527440055","display_name":"Resistance To Targeted Immunotherapies:CART19 as a Paradigm","funder_award_id":"R00CA212302","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000876787","display_name":"MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER","funder_award_id":"R37CA262362","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000904249","display_name":"Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19","funder_award_id":"P01CA214278","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4366769401.pdf","grobid_xml":"https://content.openalex.org/works/W4366769401.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1983143892","https://openalex.org/W2046562334","https://openalex.org/W2137831174","https://openalex.org/W2142300779","https://openalex.org/W2156748975","https://openalex.org/W2167550136","https://openalex.org/W2529896336","https://openalex.org/W2740938625","https://openalex.org/W2747774814","https://openalex.org/W2750694869","https://openalex.org/W2753432434","https://openalex.org/W2787301955","https://openalex.org/W2793516777","https://openalex.org/W2801641802","https://openalex.org/W2804588678","https://openalex.org/W2886131798","https://openalex.org/W2893691711","https://openalex.org/W2897815318","https://openalex.org/W2901850955","https://openalex.org/W2903062212","https://openalex.org/W2922068441","https://openalex.org/W2947746385","https://openalex.org/W2962316213","https://openalex.org/W2963298310","https://openalex.org/W3004611567","https://openalex.org/W3040437182","https://openalex.org/W3089967262","https://openalex.org/W3110234128","https://openalex.org/W3132778321","https://openalex.org/W3137422569","https://openalex.org/W3162968491","https://openalex.org/W3173096232","https://openalex.org/W3181045823","https://openalex.org/W3193095160","https://openalex.org/W3217557393","https://openalex.org/W4200626931","https://openalex.org/W4210589143","https://openalex.org/W4220773618","https://openalex.org/W4220882995","https://openalex.org/W4229445969"],"related_works":["https://openalex.org/W3080152226","https://openalex.org/W2969180340","https://openalex.org/W3140894956","https://openalex.org/W4384925159","https://openalex.org/W4224246779","https://openalex.org/W4281677392","https://openalex.org/W4214878654","https://openalex.org/W2091014339","https://openalex.org/W4412817314","https://openalex.org/W1985984631"],"abstract_inverted_index":{"The":[0,25],"2022":[1],"Immunotherapy":[2,81],"Bridge":[3,82],"congress":[4],"(November":[5],"30-December":[6],"1,":[7],"Naples,":[8],"Italy)":[9],"featured":[10],"a":[11,41],"Great":[12,83],"Debate":[13],"session":[14],"which":[15],"addressed":[16],"three":[17],"contemporary":[18],"topics":[19],"in":[20,43,79,114],"the":[21,44,49,62,77,80,89,97,101,120],"field":[22],"of":[23,46,51,64,96,116,119],"immunotherapy.":[24],"debates":[26],"included":[27],"counterpoint":[28],"views":[29],"from":[30],"leading":[31],"experts":[32],"and":[33,61,100,124],"considered":[34],"whether":[35],"adoptive":[36],"cell":[37,69,73],"therapy":[38],"(ACT)":[39],"has":[40],"role":[42,63],"treatment":[45],"solid":[47],"tumors,":[48],"use":[50],"peripheral/blood":[52],"biomarkers":[53,57],"versus":[54,70],"tumor":[55],"microenvironment":[56],"for":[58],"cancer":[59],"immunotherapy":[60],"chimeric":[65],"antigen":[66],"receptor":[67],"T":[68],"natural":[71],"killer":[72],"therapy.":[74],"As":[75],"is":[76],"tradition":[78],"Debates,":[84],"speakers":[85],"are":[86],"invited":[87],"by":[88],"meeting":[90],"Chairs":[91],"to":[92],"express":[93],"one":[94],"side":[95,118],"assigned":[98],"debate":[99],"opinions":[102],"given":[103],"may":[104],"not":[105],"fully":[106],"reflect":[107],"their":[108],"own":[109],"personal":[110],"views.":[111],"Audiences":[112],"voted":[113],"favour":[115],"either":[117],"topic":[121],"both":[122],"before":[123],"after":[125],"each":[126],"debate.":[127]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-04-25T00:00:00"}
